Journey Medical Investor Presentation - JAN 2025.pdf

1、1|2025 Journey Medical Corporation.All rights reserved.INVESTOR PRESENTATIONJanuary 2025PRESENTED BY:Claude Maraoui Co-Founder,President and CEOJoseph BeneschChief Financial OfficerSrinivas Sidgiddi,M.D.Vice President,Research&Development2|2025 Journey Medical Corporation.All rights reserved.FORWARD

2、-LOOKING STATEMENTSFORWARD-LOOKING STATEMENTSThis press release may contain“forward-looking statements”within the meaning of Section 27A of the Securities Act of 1933,as amended,and Section 21E of the Securities Exchange Act of 1934,as amended.As used below and throughout this press release,the word

3、s“the Company”,“we”,“us”and“our”may refer to Journey Medical.Such statements include,but are not limited to,any statements relating to our growth strategy and product development programs and any other statements that are not historical facts.The words“anticipate,”“believe,”“estimate,”“may,”“expect,

4、”“will,”“could,”“project,”“intend”and similar expressions are generally intended to identify forward-looking statements.Forward-looking statements are based on managements current expectations and are subject to risks and uncertainties that could negatively affect our business,operating results,fina

5、ncial condition and stock price.Factors that could cause actual results to differ materially from those currently anticipated include:the fact that our products and product candidates are subject to time and cost intensive regulation and clinical testing and as a result,may never be successfully dev

6、eloped or commercialized;a substantial portion of our sales derive from products that may become subject to third-party generic competition,the introduction of new competitor products,or an increase in market share of existing competitor products,any of which could have a significant adverse impact